


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-0.31%
-1.07%
-0.08%
TEVA
Teva Pharma
$32.14
Strengths

Earnings are forecast to grow

Trading below its fair value
TEVA Price Performance
$31.89 (+0.78%)
$20.23 (+58.87%)
$18.75 (+71.41%)
$16.59 (+93.73%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings

Revenue increase YoY
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value
![]()
TEVA Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
TEVA Street Sentiment is extremely bullish and have positive views on the near-term outlook
TEVA has Low risk level

Average key support and resistance price levels
RPRX
40.51
+0.26%
NVS
149.12
+1.35%
REGN
762.65
+1.21%
PFE
25.88
+0.90%
MRK
107.40
-0.72%
What is TEVA current stock price?
What are TEVA stock strengths?
What is TEVA Risk Level?
What is TEVA market cap and volume?
What is TEVA current Stock IQ?
Should I buy TEVA stock right now?
Is TEVA a Strong Buy right now?
What does a 'Strong Buy' rating mean for TEVA?
What does a 'Strong Sell' rating mean for TEVA?
What factors influence TEVA's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-0.31%
-1.07%
-0.08%
TEVA
Teva Pharma
Current Price
$32.14
Stock Insights
Strengths

Earnings are forecast to grow

Trading below its fair value
Linked to TEVA
RPRX
40.51
+0.26%
NVS
149.12
+1.35%
REGN
762.65
+1.21%
PFE
25.88
+0.90%
MRK
107.40
-0.72%
Recently Viewed
TEVA
Teva Pharma
32.14
+1.04%
DRVN
Driven Brands Holdin
16.08
-0.68%
VUZI
Vuzix
2.80
-6.04%
ENVX
Enovix Corporation C
7.20
-4.38%
ALSN
Allison Transmission
109.63
+0.05%

TEVA Price Performance
$31.89 (+0.78%)
$20.23 (+58.87%)
$18.75 (+71.41%)
$16.59 (+93.73%)
TEVA Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings

Revenue increase YoY
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value
![]()
TEVA Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
TEVA Street Sentiment is extremely bullish and have positive views on the near-term outlook
TEVA has Low risk level

Average key support and resistance price levels
Overall Wall Street Rating
STRONG BUY
Dec 30, 2025
Upgrade
BB
Dec 24, 2025
Upgrade
BB
S&P Global Ratings
Dec 23, 2025
Reiterate
Overweight
Piper Sandler
Dec 17, 2025
Reiterate
Overweight
JP Morgan
Dec 17, 2025
Initiate
Buy
BofA
TEVA Stock IQ
TEVA Latest Analysis
What Analyst Projections for Key Metrics Reveal About Teva Pharmaceutical Industries (TEVA) Q4 Earnings. Get a deeper insight into the potential performance of Teva Pharmaceutical Industries (TEVA) for the quarter ended December 2025 by going beyond Wall Streets top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Fri Jan 23, 2026
ESGD SPOT SE TEVA: Large Outflows Detected at ETF. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares ESG Aware MSCI EAFE ETF (Symbol: ESGD) where we have detected an approximate $106.9 million dollar outflow -- thats a 1.0% decrease week ov
Wed Jan 21, 2026
ANIP vs. TEVA: Which Drug Stock Is the Better Buy Right Now?. ANI Pharmaceuticals rare disease growth led by surging Cortrophin Gel sales is outpacing Tevas slower sales momentum in this head-to-head stock comparison.
Fri Jan 16, 2026
Teva Pharmaceutical Industries Ltd. (TEVA) is a Top-Ranked Momentum Stock: Should You Buy?. Whether youre a value growth or momentum investor finding strong stocks becomes easier with the Zacks Style Scores a top feature of the Zacks Premium research service.
Thu Jan 15, 2026
AJOVY® (fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and Adolescents with Episodic Migraine Compared to Placebo in the SPACE Trial. Results Published in New England Journal of Medicine. PARSIPPANY N.J. and TEL AVIV Israel Jan. 14 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals a United States affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that the New England Journal of Medicine (NEJM) has published pivotal Phase 3
Wed Jan 14, 2026
Teva Pharmaceutical Industries Limited (TEVA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript.
Tue Jan 13, 2026
Teva Pharmaceutical Industries Limited (TEVA) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow.
Tue Jan 13, 2026
Judge Denies Teva Bid To Pause Paragard Copper Contraceptive Device Lawsuit Trial. A Georgia federal judge on Monday reportedly denied TEVA) a request to delay the first trial in thousands of lawsuits alleging its Paragard (IUD) can fracture during removal.Paragard is a non-hormonal contraceptive device made of copper that can remain implanted for years.United States District Judge The company had asked the court to pause the case while it appealed an earlier decision rejecting Teva'.s atte
Tue Jan 13, 2026
Why Teva Pharmaceutical Industries Ltd. (TEVA) is a Top Value Stock for the Long-Term. Wondering how to pick strong market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Mon Jan 12, 2026
EFA SPOT SE TEVA: ETF Inflow Alert. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares MSCI EAFE ETF (Symbol: EFA) where we have detected an approximate $355.7 million dollar inflow -- thats a 0.5% increase week over week in ou
Mon Jan 12, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
TEVA Stock trends
TEVA Stock performance
TEVA Stock analysis
TEVA investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.